市场调查报告书
商品编码
1184395
Optum和Change Healthcare的合併Optum/Change Healthcare Merger |
2021年1月,OptumChange 发表了收购Healthcare的意向。可是,因为美国司法部2022年2月由于反竞争上的疑虑阻止了这个收购,合併仍悬而未决。这样的合併,Optum的母公司,美国最大的保险公司 UnitedHealth Group,将获得竞争对手的机密资料。法律上的手续进行中,审判定于2022年8月1日进行。
本报告提供合併的Optum和Change Healthcare客户的反应,其影响认识的介绍。2021年3月~2022年4月,KLAS从46组织对48人进行了采访。受访者中,9%是Optum客户,56%是Change Healthcare客户,35%为两供应商客户。
In January 2021, Optum announced their intentions to acquire Change Healthcare. The merger remains unfinalized, however, as the US Department of Justice blocked the deal in February 2022 due to anticompetition concerns-such a merger would give UnitedHealth Group, Optum's parent company and the nation's largest insurer, access to rivals' sensitive data. The legal proceeding is ongoing and scheduled to go to trial August 1, 2022. This report shares Optum and Change Healthcare customers' reactions to the merger and their perceptions of its impact. Between March 2021 and April 2022, KLAS interviewed 48 individuals from 46 unique organizations; of these respondents, 9% are Optum customers, 56% are Change Healthcare customers, and 35% are customers of both vendors.